Imvax, Inc. — Form D
Imvax, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-30. The offering totals $112.4M, of which $112.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-30
- Form: D
- Accession: 0001708970-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $112.4M
- Amount sold: $112.4M
- Investors: 19
- Date of first sale: 2020-07-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372102
Issuer
- Name: Imvax, Inc.
- CIK: 0001708970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 601 WALNUT STREET, SUITE 440, PHILADELPHIA, PA, 19106
- Phone: 215-485-0071
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Steven W Altschuler | Director | Philadelphia, PA |
| David Andrews | Director | STAMFORD, CT |
| Ira W Brind | Director | Philadelphia, PA |
| David W Bunning | Director | Philadelphia, PA |
| Peter W Corr | Director | Philadelphia, PA |
| Wendy W DiCicco | Director | Philadelphia, PA |
| John W Furey | Director | Philadelphia, PA |
| Ted W Koutouzis | Director | Philadelphia, PA |
| Thomas W Pfisterer | Director | Philadelphia, PA |
| David Andrews | Executive Officer | STAMFORD, CT |
| Peter W Corr | Executive Officer | Philadelphia, PA |
| John W Furey | Executive Officer | Philadelphia, PA |
| Arthur W Howe | Executive Officer | Philadelphia, PA |
| Arthur W Howe | Director | Philadelphia, PA |
Other filings by this issuer (2)
More